“…Derivatives of [1,2,4] triazolo [4,3-a]quinazolin-5(4H)-one, which are representatives of the important class of condensed heterocycles possessing a wide range of the biological activity, attract particular interest in this direction. Among their potential pharmacologically significant properties the H1-antihistaminic [1][2][3][4][5][6][7][8][9][10][11], anticonvulsant [12], antibacterial [13][14][15], antitubercular [13,15], antifungal [13,14], anticancer [15], anti-asthmatic [10,16], antiHIV [13], anti-allergic [16], anti-inflammatory [16,17] bioactivities should be mentioned. It determines the prospects for developing synthetic approaches to fundamentally new compounds of the specified class.…”